Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus

131Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

The effects on diabetic control of the relative cardio-selective beta-blocker metoprolol and the non-selective drug propranolol were compared in 20 hypertensive diabetic patients receiving diet alone or diet and oral hypoglycaemic agents. Each drug was given for one month in a double-blind, cross-over study. Fasting, noon, and mid-afternoon blood sugar concentrations rose by 10-1.5 mmol/1 (18–27 mg/100 ml). The rise with propranolol was not significantly greater than with metoprolol. In a few patients the rise was clinically important. The small overall change observed in diabetic control should not deter the use of beta-blockers in non-insulin-dependent diabetics, provided control is carefully monitored at the onset of treatment. © 1979, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Poole, P. H., & Barber, S. G. (1979). Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. British Medical Journal, 1(6157), 159. https://doi.org/10.1136/bmj.1.6157.159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free